{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:29:04Z","timestamp":1759580944616,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1016\/s0002-9343(02)01161-0","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T13:00:52Z","timestamp":1032267652000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Low Fc\u03b3 receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty\u2019s syndrome or systemic lupus erythematosus"],"prefix":"10.1016","volume":"113","author":[{"given":"Bernhard","family":"Hellmich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Csernok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masja","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert E.G.K.R","family":"von dem Borne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang L","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(02)01161-0_BIB1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archinte.1987.00370050111019","article-title":"Factors influencing the incidence of infections in Felty\u2019s syndrome","volume":"147","author":"Breedveld","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.41.5.486","article-title":"Long-term outcome in Felty\u2019s syndrome","volume":"41","author":"Thorne","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780390906","article-title":"Risk factors for serious infections during treatment with cyclophosphamide and high dose corticosteroids for systemic lupus erythematosus","volume":"39","author":"Pryor","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/rheumatology\/27.3.191","article-title":"Neutropenia and infections in Felty\u2019s syndrome","volume":"27","author":"Breedveld","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome","volume":"69","author":"Campion","year":"1990","journal-title":"Medicine"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archinte.1978.03630280059020","article-title":"Splenectomy for Felty\u2019s syndrome","volume":"138","author":"Laszlo","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0268-960X(96)90024-7","article-title":"Treatment of the neutropenia of Felty syndrome","volume":"10","author":"Rashba","year":"1996","journal-title":"Blood Rev"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","article-title":"Methotrexate treatment in Felty\u2019s syndrome","volume":"37","author":"Wassenberg","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(99)80040-7","article-title":"Treatment of severe neutropenia due to Felty\u2019s syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor","volume":"29","author":"Hellmich","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB10","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V91.10.3962","article-title":"Clinical value of IgG Fc receptor type III in plasma from patients with chronic idiopathic neutropenia","volume":"91","author":"Koene","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1172\/JCI114727","article-title":"Soluble Fc gamma receptor III in plasma originates from release by neutrophils","volume":"86","author":"Huizinga","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.1994.tb08298.x","article-title":"The plasma concentration of soluble Fc-gamma-receptor III is related to production of neutrophils","volume":"87","author":"Huizinga","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB13","first-page":"228","article-title":"Measurement and clinical significance of circulating hematopoietic growth factor levels","volume":"1","author":"Cebon","year":"1994","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.1994.tb04725.x","article-title":"Endogenous haematopoietic growth factors in neutropenia and infection","volume":"86","author":"Cebon","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/AAC.40.4.988","article-title":"Levels of recombinant human granulocyte-colony stimulating factor in serum are inversely correlated with circulating neutrophil counts","volume":"40","author":"Takatani","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB19","first-page":"677","article-title":"Fc receptors on granulocytes from patients with rheumatoid arthritis and Felty\u2019s syndrome","volume":"55","author":"Breedveld","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(80)90420-9","article-title":"Neutrophil kinetics in Felty\u2019s syndrome","volume":"69","author":"Joyce","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB21","first-page":"109","article-title":"Serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation","volume":"21","author":"Haas","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characterisic (ROC) plots","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristics (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/S0002-9343(02)01161-0_BIB24","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood.V76.10.1962.1962","article-title":"Levels of serum granulocyte colony-stimulating factor in patients with infections","volume":"76","author":"Kawakami","year":"1990","journal-title":"Blood"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302011610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934302011610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:21:45Z","timestamp":1757578905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934302011610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0002934302011610"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(02)01161-0","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Fc\u03b3 receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty\u2019s syndrome or systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(02)01161-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}